Health Care Equipment and Services

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Caution
Medium Risk


Coloplast US, a healthcare company, scored a 65 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, the company increases the risk of dividing employees, alienating customers and harming shareholders. It also uses sex and gender ideology criteria in marketing. Coloplast uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Coloplast does not provide viewpoint protections for its employees. However, the company has not publicly terminated business based on views or beliefs. For these reasons, Coloplast receives a Medium Risk rating.

Generate Reports